Clinical Trials Browser

Phase 1/2 × bexmarilimab × Clear all

NCT05428969 2026-04-23

BEXMAB

Phase 1/2 Active not recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms

NCT07460986 2026-03-10

BEXAR

Phase 1/2 Not yet recruiting

Sarcoma

NCT03733990 2025-04-02

A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)

Phase 1/2 Completed

216 enrolled 17 charts

Neoplasms

NCT05104905 2022-05-11

RENACOL

Phase 1/2 Withdrawn

GastrointestinalGenitourinary

Carcinoma, Renal Cell, Colonic Neoplasms